跳至主要内容
临床试验/IRCT20200419047128N2
IRCT20200419047128N2已完成3 期

Evaluation of the effect of quercetin on the effectiveness of antiviral drug regimen in patients with COVID19

Ahvaz University of Medical Sciences0 个研究点目标入组 60 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
no limit 至 no limit(—)
性别
All

入选标准

  • Polymerase chain reaction (PCR) confirmed infection with COVID19
  • Lung involvement confirmed with chest imaging Hospitalized with: Fever (axillar or oral temperature = 38.0 °centigrade(C) or =38.6°centigrade tympanic or rectal) Or Cough
  • Willingness of study participant to accept randomization to any assigned treatment arm
  • Acceptance of non-participation in another study before the 28th day of the study

排除标准

  • Autoimmune diseases (lupus, MS, etc.)
  • Hepatic failure Hepatit B, C,
  • pregnant and lactating women Not consent to participate in the study

研究者

相似试验